Prolonged Idasanutlin Rg7388 Treatment Leads To The Generation Of P53
Prolonged Idasanutlin (RG7388) Treatment Leads to the Generation of p53 ...
Prolonged Idasanutlin (RG7388) Treatment Leads to the Generation of p53 ...
Prolonged Idasanutlin (RG7388) Treatment Leads to the Generation of p53 ...
(PDF) Prolonged Idasanutlin (RG7388) Treatment Leads to the Generation ...
(PDF) Prolonged Idasanutlin (RG7388) Treatment Leads to the Generation ...
The susceptibility of DIPG cells to RG7388 is TP53-dependent. A The p53 ...
RG7388 upregulates mRNA and protein expression of the p53 pathway. (a ...
The MDM2 small-molecule inhibitor RG7388 leads to potent tumor ...
The MDM2 small-molecule inhibitor RG7388 leads to potent tumor ...
Combined treatment with tofacitinib and idasanutlin prolonged the ...
Advertisement Space (300x250)
The Prolonged Half-Life of the p53 Missense Variant R248Q Promotes ...
Antiproliferative activity of RG7388 (A) and activation of the p53 (B ...
RG7388 leads to a significant dose-dependent increase in apoptosis in ...
RG7388 treatment induces tumor apoptosis in p53 wild-type neuroblastoma ...
RG7388 treatment induces tumor apoptosis in p53 wild-type neuroblastoma ...
RG7388 treatment induces cell cycle arrest and/or apoptosis in p53 wt ...
The mitochondrial translocation of p53 and p53-induced production of ...
The other antagonists of MDM2-p53 interaction, idasanutlin and RG7112 ...
Combined treatment of RG7388 and pemetrexed synergistically induced ...
(PDF) Pre-clinical evaluation of the MDM2-p53 antagonist RG7388 alone ...
Advertisement Space (336x280)
RG7388 treatment induces cell cycle arrest and/or apoptosis in p53 wt ...
Pre-clinical evaluation of the MDM2-p53 antagonist RG7388 alone and in ...
Idasanutlin sensitizes macrophages to apoptosis by the Fas-stimulating ...
Pre-clinical evaluation of the MDM2-p53 antagonist RG7388 alone and in ...
RG7388 treatment induces cell cycle arrest and/or apoptosis in p53 wt ...
Pre-clinical evaluation of the MDM2-p53 antagonist RG7388 alone and in ...
Combined treatment of RG7388 and pemetrexed suppressed wtTP53‐RTK NSCLC ...
RG7388 induces mRNA upregulation of proapoptotic p53 target genes in ...
GSK2830371 combination with RG7388 enhanced the inhibition of colony ...
The development of idasanutlin-resistant cell populations from ...
Advertisement Space (336x280)
Synbio Technologies - The Syno® 3.0 Next Generation Gene Synthesis ...
P53 pathway was up-regulated after RG7388 treatment. A Hierarchical ...
RG7388 inhibits tumor growth in established p53 wild-type neuroblastoma ...
Idasanutlin concentration-dependently activates p53 in human ...
Idasanutlin concentration-dependently activates p53 in human ...
Combined targeting of EGFR-driven glucose uptake and p53 suppresses ...